
Cardinal Health (CAH) Stock Forecast & Price Target
Cardinal Health (CAH) Analyst Ratings
Bulls say
Cardinal Health is financially stable and has a diversified portfolio with a strong presence not only in the US, but also in Canada and Europe. With their increased focus on higher-growth segments and opportunities for expansion, the company is poised for future success and continued growth. Furthermore, as supply chains and healthcare delivery continue to evolve, Cardinal Health's distribution capabilities and partnerships with key stakeholders put them in a favorable position for sustainability and profitability.
Bears say
Cardinal Health is facing potential challenges in the form of changes in tax rates, potential competition, and overall uncertainty, but analysts predict that growth from new customers and expansion into specialty services will outpace long-term targets. Additionally, the company's recent acquisitions in the specialty space and partnership with CVS in the generic market may help close the performance gap with competitors. However, external factors such as changes in drug pricing and global disruptions may affect profitability and cash flow, but the company has implemented measures to minimize these risks and is expected to continue seeing revenue growth in the future.
This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.
Cardinal Health (CAH) Analyst Forecast & Price Prediction
Start investing in Cardinal Health (CAH)
Order type
Buy in
Order amount
Est. shares
0 shares